Secondary’s Announced 2.11.2015
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. To subscribe to his secondary ratings, click here. Company: Transition Therapeutics Inc. Symbol: TTHI Price: Last trade $7.08 Trade Date: 2/12 Shares:[…]